Mostrar el registro sencillo del ítem
Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
| dc.contributor.author | Guo, Xiaoxia | |
| dc.contributor.author | Xu, Bing | |
| dc.contributor.author | Pandey, Shuchita | |
| dc.contributor.author | Goessl, Elisabeth | |
| dc.contributor.author | Brown, James | |
| dc.contributor.author | Armesilla, Angel L. | |
| dc.contributor.author | Darling, J. L. | |
| dc.contributor.author | Wang, Weiguang | |
| dc.date.accessioned | 2025-01-21T17:18:10Z | |
| dc.date.available | 2025-01-21T17:18:10Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | Guo, X., Xu, B., Pandey, S., Goessl, E., Brown, J., Armesilla, A. L., ... & Wang, W. (2010). Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer letters, 290(1), 104-113. https://doi.org/10.1016/j.canlet.2009.09.002 | es |
| dc.identifier.issn | 0304-3835 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12020/1560 | |
| dc.description.abstract | Most of the gemcitabine (dFdC) resistant cell lines manifested high NFkappaB activity. The NFkappaB activity can be induced by dFdC and 5-FU exposure. The chemosensitizing effect of disulfiram (DS), an anti-alcoholism drug and NFkappaB inhibitor, and copper (Cu) on the chemoresistant cell lines was examined. The DS/Cu complex significantly enhanced the cytotoxicity of dFdC (resistant cells: 12.2-1085-fold) and completely reversed the dFdC resistance in the resitant cell lines. The dFdC-induced NFkappaB activity was markedly inhibited by DS/Cu complex. The data from this study indicated that DS may be used in clinic to improve the therapeutic effect of dFdC in breast and colon cancer patients. | es |
| dc.language.iso | en | es |
| dc.publisher | Elsevier Ireland Ltd | es |
| dc.title | Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines | es |
| dc.type | article | es |
| dc.identifier.doi | https://doi.org/10.1016/j.canlet.2009.09.002 | |
| dc.issue.number | 1 | es |
| dc.journal.title | Cancer Letters | es |
| dc.page.initial | 104 | es |
| dc.page.final | 113 | es |
| dc.rights.accessRights | closedAccess | es |
| dc.subject.area | Ciencias Biomédicas | es |
| dc.subject.keyword | NFkB | es |
| dc.subject.keyword | Disulfiram | es |
| dc.subject.keyword | Gemcitabine Resistance | es |
| dc.subject.keyword | Colorectal Cancer | es |
| dc.subject.keyword | Breast Cancer | es |
| dc.subject.unesco | 32 Ciencias Médicas | es |
| dc.volume.number | 290 | es |
Ficheros en el ítem
| Fichero/s | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||



